...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AGM Sept. 12, 2018
Reply New Message
Back To Forum List View

Annual General Meeting announcement for both Resverlogix and Zenith posted on SEDAR. September 12, 2018 for both.

3 Recommendations
Icon president Re: AGM Sept. 12, 2018
3
tada
Jun 29, 2018 11:33PM
Re: AGM Sept. 12, 2018
4
coldnewfie
Jun 29, 2018 11:58PM
Icon president Re: AGM Sept. 12, 2018
3
SanFrancisco99
Jun 30, 2018 10:09AM
Icon president Re: AGM Sept. 12, 2018
5
BearDownAZ
Jun 30, 2018 10:59AM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply